Your browser does not support JavaScript!
Logo de Labiotech.eu

Labiotech.eu Source d'actualité

Une actualité de Labiotech.eu a été ajouté(e)
Aujourd'hui à 08:34
3 promising biotech approaches to treat Hunter syndrome, a rare genetic disorder
Discover three promising approaches being investigated to treat Hunter syndrome, a rare genetic disorder affecting children. The post 3 promising biotech approaches to treat Hunter syndrome, a rare...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Hier à 08:34
Trade war: how new U.S. tariffs will impact the biopharma industry
The U.S. plans to impose trade tariffs on imports. How does this affect the biopharma industry? The post Trade war: how new U.S. tariffs will impact the biopharma industry appeared first on...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 2 jours
T cell engagers: A promising, fast-growing field for cancer and autoimmune disease treatments
T cell engagers represent a novel approach to tuning the immune system to target and kill tumor cells, expanding treatment options for cancer. The post T cell engagers: A promising, fast-growing...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 3 jours
Biotech’s legal storm: Why securities class action lawsuits are surging
Find out about what's behind the increase of securities class action lawsuits in the biotech industry and how to prevent them. The post Biotech’s legal storm: Why securities class action lawsuits...
www.labiotech.eu
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours
Reversing cancer mechanisms to fight back against solid tumors
This week, we have a conversation with Catalym's Eugen Leo about Visugromab is a monoclonal antibody that neutralizes the tumor-derived growth differentiation factor-15. The post Reversing cancer...
www.labiotech.eu
Charger plus d'actualités

Informations juridiques

SIREN / SIRET - DE Labiotech

Adresse
Berlin Berlin DE Allemagne